American Well (AMWL) to Release Quarterly Earnings on Wednesday

American Well (NYSE:AMWL) will be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. American Well has set its FY 2025 guidance at EPS and its FY 2024 guidance at EPS.Parties that wish to listen to the company’s conference call can do so using this link.

American Well (NYSE:AMWL) last announced its quarterly earnings results on Wednesday, February 14th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.02. American Well had a negative net margin of 260.63% and a negative return on equity of 40.19%. The firm had revenue of $70.68 million for the quarter, compared to analyst estimates of $70.16 million. During the same period last year, the business earned ($0.22) EPS. American Well’s revenue for the quarter was down 10.8% compared to the same quarter last year. On average, analysts expect American Well to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

American Well Price Performance

Shares of NYSE:AMWL opened at $0.53 on Monday. The company’s fifty day moving average price is $0.84 and its 200 day moving average price is $1.08. American Well has a 12 month low of $0.50 and a 12 month high of $2.74. The firm has a market capitalization of $152.72 million, a P/E ratio of -0.22 and a beta of 0.99.

Insider Buying and Selling at American Well

In other news, CFO Robert Shepardson sold 319,214 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $347,943.26. Following the transaction, the chief financial officer now owns 2,845,148 shares of the company’s stock, valued at $3,101,211.32. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CFO Robert Shepardson sold 319,214 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $1.09, for a total value of $347,943.26. Following the completion of the sale, the chief financial officer now owns 2,845,148 shares in the company, valued at approximately $3,101,211.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Kurt Knight sold 283,079 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $308,556.11. Following the transaction, the chief operating officer now owns 3,114,004 shares in the company, valued at $3,394,264.36. The disclosure for this sale can be found here. Insiders sold a total of 1,169,038 shares of company stock valued at $1,267,410 in the last ninety days. Insiders own 12.94% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley dropped their price objective on shares of American Well from $1.75 to $1.00 and set an “equal weight” rating on the stock in a research note on Monday, April 15th.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.